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Tubulopathy in nephrolithiasis: Consequence rather than cause. To
address whether a renal tubular dysfunction is encountered in a
particular patient subgroup with urolithiasis, the following parameters
of tubular function were measured in urine taken in the morning from
214 stone formers after fasting: pH, excretion of lysozyme and y-
glutamyl transferase (y-GT); fractional excretion (FE) of glucose,
insulin, Mg, K, and HCO3 after an alkali loading; and the renal
threshold for phosphate (TmP/GFR). The following diagnoses were
made in the patient group: primary hyperparathyroidism (N = 8),
medullary sponge kidneys (N = 21), hyperuricemia (N = 10), cystinuria(N = 2), struvite stone disease (N = 6), idiopathic hypercalciuria of the
absorptive (N = 25), dietary (N = 69) or renal (N = 7) type, and
normocalciunc idiopathic urolithiasis (N = 66). In 31% of the patients
TmP/GFR was below 0.80 mmole/liter and in 13% of the patients, FE
HCO3 after alkali loading was above normal. Urinary excretion of
lysozyme and that of y-GT both were elevated in 17% of the patients.
FE glucose, FE insulin, FE Mg, and FE K were elevated in 8, 9, 3, and
7% of the patients, respectively. This study demonstrates that a
significant number of stone formers present with signs of renal tubular
dysfunction, primarily involving the proximal tubule since apparent
leaks of phosphate and of bicarbonate were most frequently encoun-
tered. The defects were not specific for a given etiologic group of
patients; on the other hand, occurrence was related to the presence of
large stones in the pyelocaliceal system at the time data were gathered.
Taken together these data suggest that the tubulopathy in nephrolithi-
asis is the consequence rather than the cause of the stone.
Previously, many investigators have regarded nephrolithiasis
as the consequence of a renal leak of a lithogenic substance:
Aibright et al [1] postulated that a leak of calcium could be the
first step of a cascade of events leading to renal stone formation
and coined the term "idiopathic hypercalciuria"; Bordier et a!
[2] extended this concept postulating that a primary leak of
phosphate could also lead to hypercalciuria and stone disease.
Both concepts were supported by numerous investigators [3—9]
and became widely accepted, although more recently many
studies have challenged them [10—14]. In addition, evidence of
various other tubular defects has been obtained in stone form-
ers, leading to enzymurias [15-16], hyperinsulinuria [17], and
renal tubular acidosis [18—21]. These observations support the
view that overall proximal tubular function might be defective
in nephrolithiasis [221.
The question of whether tubular defects could be the conse-
quence of the disease, rather than the cause, is an issue
Received for publication November 12, 1984,
and in revised form August 19, 1985
© 1986 by the International Society of Nephrology
unaddressed so far. Therefore, this study was undertaken to
determine whether "leaky" tubules are a specific sign of a
well-defined subgroup of idiopathic stone formers, such as renal
hypercalciuria. The results support the view that tubular de-
fects are common in many patients with nephrolithiasis, as a
consequence of stone formation in the pyelocaliceal system.
Methods
Classification of renal stone formers
This study involves 167 men (aged 21 to 76) and 47 women
(aged 18 to 87) who passed one or more renal stones prior to
enrollment in this study. The following ambulatory protocol
was used to classify the cause of nephrolithiasis. Three 24-hr
urine samples were collected when patients were on a free-
choice diet, a calcium-enriched diet (+ 3 g Ca• day' for 3
days), and a low-calcium diet (< 400 mg day) [23]. Aliquots
of urine were analyzed for the concentration of Na, Ca, urate,
and creatinine.
After the first urine collection (on the free-choice diet), a
blood sample taken after the patients fasted was analyzed for
total Ca, P, Mg, K, Cl, HCO3, total protein, glucose, insulin,
and, in some patients parathyroid hormone. A morning urine
sample was obtained also after the patients fasted. Urine pH
was measured and the sediment was examined microscopically.
A urine culture was performed in patients with urogenital signs
or symptoms and/or evidence by x-ray of stone formation in the
pyelocaliceal system.
An intravenous pyelogram was performed in all patients and
reviewed by a radiologist who was unaware of the clinical
diagnosis for evidence of medullary sponge kidney. The diag-
nosis of medullary sponge kidney was based on the presence of
pyramidal brush and/or pyramidal cysts in the absence of signs
of obstruction [24—27]. The diagnosis was accepted if one single
papilla was involved, provided the lesion was well-defined and
there was no evidence of other caliceal lesions such as diver-
ticula or pyelogenic cysts. The sole persistence of a papillary
blush for 10 or more mm after rapid injection of contrast
medium (60 ml of 76% Urografin) was regarded as a minor form
of medullary sponge kidney [28].
The following categories of stone formers were identified:
primary hyperparathyroidism in eight patients (3 men/S
women), medullary sponge kidney (16 men/S women),
hyperuricemia with or without concurrent hyperuricosuria (10
men/0 women), cystinuria (1 man/i woman), and struvite stone
disease (1 man/S women). The remaining 167 patients were
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classified as idiopathic stone formers (1SF) and further catego-
rized, based on urinary calcium excretion, as normocalciuric
(53 menll3 women) or idiopathic hypercalciuric (IHC) (83
men/l8 women). Among the 101 hypercalciuric patients, there
were 25 (16/9) with absorptive hypercalciuria, 69 (62/7) with
dietary hypercalciuria, and 7 (5/2) with renal hypercalciuria.
The diagnosis of absorptive IHC required excessive calcium
excretion on the high calcium diet, and normal calcium excre-
tion on the low calcium diet. Dietary IHC had high calcium
excretion rates either on free-choice diet only, or on the low
calcium diet in the presence of excessive sodium and/or purine
intake, and/or obesity with concurrent hyperinsulinemia. The
term renal IHC was reserved for patients with hypercalciuria on
the low calcium diet that could not be explained by any of the
three previously mentioned factors.
Assessment of tubular function
Proximal and distal tubular function was estimated in stone
formers by comparing the renal excretion of electrolytes and
nonelectrolyte substances with normal values derived from
healthy volunteers studied under the same conditions in our
clinic. The following tests were performed: From urine and
blood samples obtained under fasting conditions after a free-
choice diet, the fractional excretion (FE) of insulin, glucose, K
and Mg' were measured, as well as the urinary concentration of
lysozyme and 7GT divided by that of creatinine. FE x was
derived from the ratio urinary concentration of x over the
plasma concentration of x factored by the ratio plasma creati-
nine level over urinary creatinine concentration. The theoreti-
cal renal threshold for phosphate (TmP/GFR) was estimated
from the nomogram of Walton and Bijvoet [30].
Urinary acidification was estimated from the plasma Cl and
HCO3 levels, and from the pH value of urine obtained in the
morning from fasting subjects after a free-choice diet and/or the
low-calcium diet. A NH4C1-loading test was performed on patients
whose urine pH exceeded 5.85 on two occasions. Of 58 eligible
subjects in this series, 37 agreed to have the analysis performed.
Following the administration of NH4C1 for 3 days (3—6 g day',
provided as 500-mg gelatine capsules), urinary acidification was
determined from the pH value of fasting morning urine. In
addition, FE HCO3 was measured after 3 days of oral alkali
loading administered as a mixture of Ca-gluconate and lactate
(15.7 g ' day'), and Ca-carbonate (2.4 g day'). The combina-
tion of Ca-HCO3 was chosen since HCO3 alone would be expected
to lower plasma ionized calcium, due to alkalinization, and stim-
ulate PTH release; the latter would have led to increased excretion
of bicarbonate. From a theoretical standpoint, this would have
been problematic. Indeed, one group of idiopathic stone formers
has been reported to have secondary hyperparathyroidism and the
response of these patients to the hypocalcemic stimulus would be
particularly marked, with apparent renal leak of bicarbonate. On
the other hand, the oral administration of Ca-HCO3 caused a
IBecause a sizeable fraction of plasma Mg is protein-bound, calculation
of the true FE Mg requires measurement of ultrafilterable Mg levels.
However, in analogy with what has been demonstrated for Ca [29],
ultrafllterable Mg can be considered to make up a reasonably constant
fraction of total Mg; therefore, for the sake of the comparisons made
herein, only this "apparent" FE Mg has been measured.
Ca-induced depression of PTH secretion which was similar in
control subjects and in each category of stone formers. This has
been estimated from plasma PTH levels and nephrogenous cyclic
AMP measurements (Jaeger, Bifi, and Burckhardt, unpublished
observations).
Determination of normal parameters of mineral metabolism
and tubular function
Normal values used in this study are based on the data
obtained in a population of 61 male (aged 24 to 66) and 21 female
(aged 20 to 59) healthy volunteers. Upper and lower normal
limits have been defined as the mean values 2 SD and are
indicated in the legends to the figures, except for urinary
excretion of calcium (UcaV), plasma level of Cl, and venous
blood bicarbonate concentration for which they read as follows:
upper normal limit of UcaV at 280 mg/24 hr for men and 230
mg/24 hr for women on a free-choice diet, at 500 mg/24 hr for
men and 400 mg/24 hr for women on the Ca-enriched diet, and
at 250 mg/24 hr for men and 200 mg/24 hr for women on the low
Ca diet; upper normal limit of plasma Cl concentration at 110
mmoles/liter and lower normal limit of venous blood HCO3 at 22
mmoles/liter.
Chemical determinations
Lysozyme was measured in urine by turbidimetry according
to a modification of the method of Litwack [31]. y-Glutamyl-
transferase (y-GT) was measured in urine according to the
recommendations of the International Federation of Clinical
Chemistry [32] and data expressed at 37°. In plasma and urine,
glucose was measured by an enzymatic technique (hexokinase
and glucose-6-phosphate dehydrogenase), and insulin according
to Herbert et al [33] as modified by Ching et al [17]. Chloride
and phosphate were measured by photometry with thiocyanate
and mercuric chloride for the former, and molybdate without
deproteinization and reading at 366 nm for the latter, Calcium
and magnesium were measured by atomic absorption, sodium
and potassium, by flame photometry, urate according to Kage-
yama, and creatinine according to Jaffé using an autoanalyser
with dialysis. Blood acid-base status and urine PCO2 were
measured with an analyser (Radiometer ABL3), and urine pH
with a pH-meter (Radiometer PHM 62).
Statistical analysis
Significance of differences between means has been tested
applying Student's t test for unpaired data. Significance of the
differences of incidence rates has been tested applying a x2 test
with Yates correction.
Results
The individual values of fasting urinary excretion of
lysozyme and y-GT are depicted in Figures 1 and 2, respec-
tively. For each parameter, values above normal were encoun-
tered in 17% of the whole population of patients. The incidence
of the lysozyme "leak" was different among the various sub-
groups of stone formers: 9.5% in the normocalciuric patients,
66% in those with renal hypercalciuria (P = 0.001), and 100% in
patients with struvite calculi (P < 0.001). Regarding the excre-
tion of 'y-GT, no such differences could be observed.
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Fig. 1. Individual values of fasting urinary excretion of lysozyme in
male (•) and female (0) stone formers of the various subgroups. The
vertical line at 17 kU/g creatinine represents the upper normal limitfor
this parameter based on measurements performed in 33 normal sub-
jects. The numbers on the left indicate the number of patients whose
urinary lysozyme was undectectable. Abbreviations are: IHC, idio-
pathic hypercalciuria; 1SF, idiopathic stone formers.
The individual values of fasting fractional excretion of glu-
cose and insulin are depicted in Figures 3 and 4, respectively.
For each of these parameters, values above normal were
relatively infrequent, (approximately 8% of the total popula-
tion), without predilection for a particular subtype of patients.
Individual values of TmP/GFR are depicted in Figure 5.
Except for patients with primary hyperparathyroidism, about
one third of the patients had a low renal threshold for phos-
phate, regardless of the cause of stone formation. The incidence
of low TmP/GFR was twice as high in patients with primary
hyperparathyroidism (63%) than in patients of the other groups.
In an effort to study function in more distal parts of the
nephron of these patients, the fractional excretion of Mg and K
were measured and the results are shown in Figures 6 and 7,
respectively. Although an abnormality in these parameters was
rare in the total population of stone formers, about 3 and 7%,
respectively, the incidence was significantly higher in patients
with struvite calculi: P < 0.005 and P = 0.01 for FE Mg and FE
K, respectively.
To measure urinary acidification function of these patients
when they fasted, urine pH was measured on 2 different
mornings (that is, after free-choice and low calcium diets).
Whereas in normal subjects urine pH was always below 5.85 (at
least on one occasion), it was above this value in 28% of the
patients tested. Figure 8 shows that a high fasting urine pH was
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more common in patients with struvite calculi (100% of the
patients, P < 0.0005), and with primary hyperparathyroidism
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Fig. 2. Individual values offasting urinary excretion of -y-GTin male (•)
and female (0) stone formers, The vertical line at 21 IU/g creatinine
indicates the upper normal limit for this parameter based on measure-
ments performed in 33 normal subjects. Abbreviations are in Figure 1.
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Fig. 3. Fractional excretion (FE) of glucose in fasting urine in male (I)
andfemale (0) stone formers. The vertical line at 525.10-6 indicates the
upper normal limit for this parameter based on measurements per-
formed in 30 normal subjects. Abbreviations are in Figure 1.
0 500
Primary
hyperparathyroidism
Medullary
sponge kidneys
Hyperuricemia
Cystinuria
Struvite
Absorptive IHC
Dietary IHC
Renal IHC
Normocalciuric 1SF
0 .:
o .
..t .4.. ...o.. 0
•o.cR4.o..o 0•Oe S
0 20 40 60 80 100 < 10
Fig. 4. Fractional excretion (FE) of insulin in fasting urine in male (I)
and female (0) stone formers. The vertical line at 55. l0 represents
the upper normal limit for this parameter based on measurements
performed in 30 normal subjects. Abbreviations are in Figure 1.
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Fig. 6. Fractional excretion (FE) of magnesium in fasting urine in male(I) and female (0) stone formers. The vertical line at 4.5 102
indicates the upper normal limit for this parameter based on measure-
ments performed in 33 normal subjects. Abbreviations are in Figure 1.
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Fig. 5. Individual values of theoretical renal threshold for phosphate
(TmP/GFR) in male (•) and female (0) stone formers. The vertical line
at 0.80 mmole/liter indicates the lower normal limit for this parameter
based on measurements performed in 46 normal subjects. Abbrevia-
tions are in Figure 1,
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Fig. 7. Fractional excretion (FE) of potassium in fasting urine in male
(•) andfemale (0) stone formers. The vertical line at 25' 102 indicates
the upper normal limit for this parameter based on measurements
0 0.5 10 1.5 2.0 performed in 32 normal subjects. Abbreviations are: IHC, idiopathic
mmoles//jter hypercalciuria; 1SF, idiopathic stone formers.
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(86% of the patients tested, P 0.003) than in the rest of the
population. On the other hand, no hyperuricemia patient had an
elevated urine pH, an observation reported by others [34—36]. A
high fasting urine pH was also uncommon in the normocalciuric
patients, compared with the rest of the population (P = 0.001),
To further evaluate the cause of the high urine pH encoun-
tered in approximately one third of the stone fotmers, a
NH4CI-loading test was performed in most of the latter patients;
the results are depicted in Figure 9. In all the patients tested but
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one, fasting urine pH decreased to or below 5.4 after 3 days of
NH4C1 loading demonstrating normal distal acidification. One
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patient, however, was refractory to both the chronic, as well as
an acute NH4CI-loading test (0.1 g/kg over 30 mm), despite
development of a marked metabolic acidosis (arterial HCO3
level at 15.8 mmoles/liter). She had medullary sponge kidneys,
severe bilateral nephrocalcinosis, and overt metabolic acidosis.
She was considered to have complete distal renal tubular
acidosis (RTA). To evaluate proximal tubular acidification
function, 102 of these patients were chronically loaded with a
known amount of alkali, and fractional excretion of bicarbonate
was measured. Data are depicted in Figure 10 and demonstrate
that 13 patients had an apparent bicarbonate leak when submit-
ted to this test, leading to the diagnosis of proximal RTA. All
patients had a normal venous blood level of bicarbonate (> 22
mmoleslliter) and chloride (< 110 mmoles/liter). They were
considered therefore to have the incomplete form of proximal
RTA.
Finally, as an approach to potential causes of this renal
tubular dysfunction in stone formers, the characteristics of
patients with multiple tubular defects (that is, at least three;
Table 1) were compared with those of patients in whom all the
aforementioned parameters had been measured and found
normal (Table 2). Fifteen patients exhibited multiple tubular
defects and 17 exhibited no defect at all. As shown in the tables,
both patient groups were similar in terms of age, sex, total
number of stones ever formed, and number of stones newly
formed over the last 2 years prior to the work-up, as well as
nephrotomies in the past. The incidence of patients with a
family history of nephrolithiasis was similar in both groups. In
addition, both groups contained patients belonging to most of
the various categories of stone formers. The only significant
difference between the two patient groups was the number of
stones present in the pyelocaliceal systems at the time of the
work-up, which was significantly larger in the group with than
in the group without tubular defects (P < 0.05). In particular the
incidence of large (that is, > 2 cm diameter) pyelic stones was
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Fig. 10. Fractional excretion (FE) of bicarbonate measured in fasting
urine after 3 days of oral alkali loading in male (•) and female (0)
stone formers. The vertical line at 15000 . 10 indicates the upper
normal limit for this parameter based on measurements performed in 28
normal subjects. See Figure 7 for abbreviations.
5.0 5.5 6.0 6.5 7.0
FIg. 8. Individual values of fasting urine pH (lowest value of two
measurements) in male (•) and female (0) stone formers. The vertical
line at 5.85 indicates the upper normal limit for this parameter based on
measurements performed in 33 normal subjects. See Figure 7 for
abbreviations.
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FIg. 9. Individual values offasting urine pH before and after 3 days on
NH4CI in 27 male (•) and 10 female (0) stone formers. The upper
normal limit is based on measurements performed in 14 normal
subjects.
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Table 1. Characteristics of the 15 patients with multiple tubular defects
Patient
Numbers 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Compared with Table 2
Sex M F F F F F F F M M F M M M F 6MI15 NS
Age, years 76 49 40 46 52 72 50 56 43 35 50 28 61 43 34 490 348 NS
Acid-base x x x x x x x x x x x x x
TmPIGFR x x x x x x x x
Lysozyme x x x x x x x x x x x x
y-clT x x x x x x
FE glucose x x x x x
FE insulin x x x
FEMg x x
FEK x x x x
Diagnosis NC NC NC NC NC PHP PHP PHP IHC-A IHC-A IHC-D IHC-D HU HU ICH-R
Family his-
tory — — — — — — — — — + — — + — + 3+115 NS
Nb of stones
formed,
total 3 3 2 2 1 2 5 2 6 >40 4 2 5 5 6 5.87±2.47a NS
Nb of stones
formed,
last 2
years 1 3 1 2 1 1 1 2 1 3 1 1 1 2 1 1.47±0.19a NS
Pyelocaliceal
stone in
place at
time of
analyses 1 2(b) 1 2(b) 0 1 1 2(u) 2(b) 0 0 1 0 0 1 0.93 P<0.05
Large (i.e.,
>2cm 0)
calculi in
place at
time of
analyses + + + + — + — — — — — — — — — 5+115 P0.03
Occurrence
of previ-
ous neph-
rotomies — — + — — — + — + — — — — + — 4+115 NS
Abbreviations: Acid-base parameters, blood HCO3 or plasma Cl concentrations, fasting urine pH, or fractional excretion of HCO3 in fasting
urine after alkali loading; X, indicates that the value of the parameters was abnormal; NC, normocalciuric idiopathic stone former; PHP, primary
hyperparathyroidism; IHC, idiopathic hypercalciuria of the absorptive (A), dietary (D) or renal (R) type; HU, hyperuricemia; MSK, medullary
sponge kidneys; (u), unilateral; (b), bilateral.
a mean SEM
significantly higher in the group with tubular defects (P =
0.015).
Discussion
This study confirms previous observations that renal tubular
defects can be encountered in patients with nephrolithiasis [1—9,
15—22]; it shows, however, that this tubulopathy occurs with a
rather even frequency in stone formers of any etiology or
subgroup.
An apparent renal leak of phosphate is by far the most
frequent of these findings. Thirty-one percent of all the patients
studied had a low renal threshold for phosphate, and this defect
was equally frequent among hypercalciuric and normocalciuric
stone formers. The latter observation agrees well with Broadus
et al [14] in whose recent study 36% of the nonhypercalciuric
patients had a low TmP/GFR. It weakens the concept of
phosphate leak as a cause of absorptive hypercalciuria via
stimulation of 1,25(OH)2D synthesis [2, 8]. However, it should
be noted that a low TmPIGFR does not necessarily reflect an
intrinsic renal tubular defect. It can be the consequence of
hypersecretion of hormones such as in primary hyperpara-
thyroidism; it might also be the consequence of dietary indis-
cretion such as a high glucose intake which has been shown to
depress tubular phosphate reabsorption both in animals [37] and
humans [381.
That many stone formers have a high urine pH has already
been appreciated [39]. The high urine pH in patients with
staghorn calculi reflects in part high ammonia generation via
urea-splitting organisms. In patients with primary hyperpara-
thyroidism, it probably reflects a PTH-induced renal leak of
bicarbonate although the existence of this effect in a chronic
condition remains to be proven. It may also be found in patients
with a high dietary intake of alkali (such as heavy club soda
drinkers or vegetarians). In hypercalciuric stone formers, how-
ever, it has classically been ascribed to a defect of the tubular
acidification mechanisms involving the terminal part of the
nephron, (distal RTA). In the present series, only one patient
had distal RTA, whereas 13% of the stone formers tested had a
high fractional excretion of bicarbonate after alkali loading, that
is, proximal RTA. This observation is surprising, because it
generally has been accepted that patients with proximal tubular
RTA have neither hypercalciuria nor stone disease [40—42].
Tubulopathy in nephrolithiasis 569
Table 2. Characteristics of the 17 patients without tubular defect
Patient
Numbers 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Sex M M M M M M M M M F F F F F F M M I1M/17
Age, years 47 50 51 46 28 36 49 38 35 60 53 31 27 28 45 44 41 41.7
Acid-base
TmPIGFR
Lysozyme
y-GT
FE glucose
FE insulin
FE Mg
FE K
Diagnosis HCI-D HCI-D HCI-D HCI-D HCI-D HCI-D HCI-A HCI-A HCI-A HCI-A HCI-A NC NC NC NC HCI-R MSK
Family his-
tory + + — — + — — + + — — — — + — + + 8+/17
Nb of stones
formed, 5.18
total 2 10 3 4 2 1 2 2 8 5 6 1 9 6 14 17 1
Nb of stones
formed,
last2 2.12a
years 1 4 2 1 1 1 1 1 2 5 3 1361 2 1
Pyelocaliceal
stone in
place at
time of 0.29
analyses 0 1 0 0 0 0 0 0 0 3(u) 0 0 0 0 1 0 0
Large (i.e.,
>2cm 0)
calculi in
place at
time of
analyses — — — — — — — — — — — — 0+/17
Occurrence
of previ-
ous neph-
rotomies — — + — — — + — — + + — 4+/17
For abbreviations, see Tab!e 1.
Indeed, delivery to the distal tubule of either bicarbonate or
citrate is increased in these patients, the former stimulating
distal calcium reabsorption [43] and the latter lowering the risk
of precipitation of calcium salts in tubular fluid [44]. Reasons for
this apparent discrepancy have not been reached, although a
similar observation has recently been made by others [20]. One
explanation could be that the defect was present in its incom-
plete form, that is, without overt metabolic acidosis; indeed, in
incomplete proximal RTA bicarbonate leakage persists because
the blood bicarbonate level remains above renal threshold; this,
in turn, leads to high urine pH, and by that to an increased risk
of precipitation of calcium phosphate.
The observation of renal leaks of lysozyme, y-glutamyl
transferase, glucose, and insulin deserves a particular mention.
Whereas the apparent phosphate and bicarbonate leakages can
always be ascribed, at least in part, to dietary indiscretions, the
latter set of data, obtained from patients in the fasting condi-
tion, cannot. This leads to the conclusion that in stone formers
of any subgroup, various transport systems of the proximal
tubule are often defective. The fact that measurable amounts of
lysozyme, insulin, and glucose appear in final urine reflects
damage to the early portion of the proximal tubule, that is, the
pars convoluta, since all of them are freely filtered but entirely
reabsorbed along this part of the nephron [45—48].On the other
hand, the presence of y-GT in urine probably reflects a damage
to a more terminal portion of the proximal tubule; indeed, y-GT
is a high molecular weight unfiltered hydrolase contained in the
brushborder membrane of the proximal tubule, with particu-
larly high density in the pars recta [49—50].
Concerning lysozyme excretion, it could have been argued
that the high urinary levels seen in patients with struvite stones
could have been liberated from leukocytes in the urine rather
than arising from tubular epithelium. In fact, this question has
been answered by a study which showed that lysozyme is
undetectable in patients with infection of the lower urinary tract
despite the presence of severe leukocyturia [51]. The different
appearance of these markers of proximal tubular dysfunction
could be partially explained by differences in sensitivity of the
various transport systems to the renal "nox." However, it
should also be emphasized that in this study, all the analyses
were performed on samples taken while patients fasted, that is,
when plasma levels are very close to the renal threshold
concentrations. For example, deriving the fractional excretions
of glucose and insulin from 24-hr urine collections instead of
from morning urine samples from fasting patients would lead to
unmask a larger number of patients with glucose or insulin
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leaks. For insulinuria, for instance, this would probably have
yielded an incidence rate closer to that reported by Ching et al
[17]. To see whether portions of the nephron beyond the pars
recta participate in the tubulopathy of the stone formers, fasting
fractional excretion of Mg and K have also been measured as
function markers of the thick ascending limb of the loop and the
terminal nephron, respectively. Contrary to what has been
stated recently [22, 52], magnesium leaks appear to be excep-
tional in stone formers, an observation which is easier to
reconcile with the classic views on lithogenesis. The leak of
potassium is less exceptional; it has been encountered in
various subgroups of stone formers with a frequency similar to
that of glucose and insulin. Its meaning is uncertain, but it could
reflect a rather rare damage of the terminal nephron of some
patients with nephrolithiasis.
Taken together, these data show that renal tubular damages
are frequently encountered in stone formers, irrespective of the
subgroup to which the patient belongs. These lesions lead
primarily to a dysfunction of the proximal tubule of which
several transport systems are involved.
With respect to the cause of the tubulopathy, two hypotheses
were considered: (1) Either the transport defects are the pri-
mary event and the stones secondary, or (2) the stones come
first and the tubular defects ensue. Because the leaky tubules
were found in stone disease of any cause but not in one specific
subgroup such as the idiopathic nephrolithiasis, and because
patients with multiple tubular defects were precisely those with
numerous and large stones within the pyelocaliceal system at
the time of the analyses, it is concluded that the tubulopathy
zncountered in nephrolithiasis is most probably the conse-
uence rather than the cause of the stone.
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